Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,661,000 | 4,099,000 | 3,887,000 | 3,910,000 | 3,982,000 |
| Cost of Goods | 1,921,000 | 2,050,000 | 2,093,000 | 2,037,000 | 2,104,000 |
| Gross Profit | 1,740,000 | 2,049,000 | 1,794,000 | 1,873,000 | 1,878,000 |
| Operating Expenses | 2,454,000 | 1,994,000 | 1,150,000 | 1,291,000 | 1,444,000 |
| Operating Income | -714,000 | 55,000 | 644,000 | 582,000 | 434,000 |
| Other Income | -236,000 | -231,000 | -267,000 | -263,000 | -287,000 |
| Pre-tax Income | -950,000 | -176,000 | 377,000 | 319,000 | 147,000 |
| Income Tax | 2,000 | -25,000 | 76,000 | 98,000 | 62,000 |
| Net Income Continuous | -952,000 | -151,000 | 301,000 | 221,000 | 85,000 |
| Minority Interests | 3,000 | 7,000 | 11,000 | 14,000 | 7,000 |
| Net Income | $-955,000 | $-158,000 | $291,000 | $207,000 | $77,000 |
| EPS Basic Total Ops | -0.86 | -0.14 | 0.26 | 0.19 | 0.07 |
| EPS Basic Continuous Ops | -0.86 | -0.14 | 0.27 | 0.20 | 0.08 |
| EPS Diluted Total Ops | -0.86 | -0.14 | 0.26 | 0.19 | 0.07 |
| EPS Diluted Continuous Ops | -0.86 | -0.14 | 0.27 | 0.20 | 0.08 |
| EBITDA(a) | $-391,000 | $375,000 | $973,000 | $887,000 | $810,000 |